Monash IVF Group is a diagnostics & research business based in Australia. Monash IVF Group shares (MVF) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Monash IVF Group has a trailing 12-month revenue of around $213.6 million. If you're looking to buy shares, check out the steps below.
Our top pick for
Low costs
Our top pick for
Education & learning
Our top pick for
Australian stocks
| 52-week range | $0.8889 - $1.32 |
|---|---|
| 50-day moving average | $1.2808 |
| 200-day moving average | $1.1718 |
| Target price | $1.37 |
| PE ratio | 22.32 |
| Dividend yield | $0.044 (3.52%) |
| Earnings per share (TTM) | $0.06 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$1.3
| 1 week (2023-11-24) | 4.00% |
|---|---|
| 1 month (2023-11-02) | -0.76% |
| 3 months (2023-09-01) | 3.17% |
| 6 months (2023-06-02) | 13.04% |
| 1 year (2022-12-02) | 30.65% |
|---|---|
| 2 years (2021-12-02) | 41.30% |
| 3 years (2020-12-02) | 78.08% |
| 5 years (2018-11-30) | 36.84% |
Valuing Monash IVF Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Monash IVF Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Monash IVF Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Monash IVF Group shares trade at around 22x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Monash IVF Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $40.4 million (£0.0 million).
The EBITDA is a measure of a Monash IVF Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $213.6 million |
|---|---|
| Operating margin TTM | 16.9% |
| Gross profit TTM | $72.8 million |
| Return on assets TTM | 5.45% |
| Return on equity TTM | 8.06% |
| Profit margin | 10.23% |
| Book value | 0.701 |
| Market capitalisation | $498.7 million |
TTM: trailing 12 months
Dividend payout ratio: 146.67% of net profits
Recently Monash IVF Group has paid out, on average, around 146.67% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.52% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Monash IVF Group shareholders could enjoy a 3.52% return on their shares, in the form of dividend payments. In Monash IVF Group's case, that would currently equate to about A$0.044 per share.
Monash IVF Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 7 September 2023 (the "ex-dividend date").
Over the last 12 months, Monash IVF Group's shares have ranged in value from as little as $0.8889 up to $1.32. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Monash IVF Group's is 1.468. This would suggest that Monash IVF Group's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Cremorne, Australia.
Looking to jump on the AI bandwagon? Here's how you can invest in ChatGPT and its parent company OpenAI from Australia.
Looking for the best performing stocks in Australia? We update this list weekly.
If you’re looking for ways to gain exposure to Bitcoin and other digital currencies, cryptocurrency ETFs could be worth exploring. Find out what crypto ETFs are and how they work in this introductory guide.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Steps to owning and managing Microsoft shares from in Australia.
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
Learn about the money market and everyday consumer money market products.
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
Follow these tips to find the best share trading platform for you.
